|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00289094 |
|
Date of registration:
|
07/02/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA
|
|
Scientific title:
|
Multi-center, Prospective, Clinical Evaluation of the PFC Sigma Rotating Platform Cruciate Retaining Versus PFC Sigma Cruciate Retaining Knee Primary Cases |
|
Date of first enrolment:
|
May 2001 |
|
Target sample size:
|
99 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00289094 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
|
|
|
Contacts
|
|
Name:
|
Tammy L O'Dell, EMT, CCRA, CCRC |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
DePuy Orthopaedics |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Osteoarthritis
- Rheumatoid Arthritis
- Other inflammatory arthritis
- Avascular necrosis of bone
Exclusion Criteria:
- Prior ipsilateral TKA
- Metabolic disorders
- Joint replacement due to autoimmune disorders
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Avascular Necrosis of Bone
|
|
Osteoarthritis
|
|
Rheumatoid Arthritis
|
|
Intervention(s)
|
|
Device: Total Knee Arthroplasty
|
|
Device: Total knee replacement
|
|
Primary Outcome(s)
|
|
Knee Society Scores
[Time Frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
|
|
Secondary Outcome(s)
|
|
Complications/Revisions
[Time Frame: On-going to end of study.]
|
|
Medical Imaging
[Time Frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
|
|
SF-12 Patient Outcomes
[Time Frame: Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|